Acadia Pharmaceuticals
Develops NUPLAZID and DAYBUE for neurological and rare diseases.
$29.17
After-hours close+0.05 (+0.18%)
At close$29.12(−2.05%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.21 | — | — |
| Aug 2026 | $0.07 | $0.18 | +164.1% |
| May 2026 | $0.04 | $0.02 | −50.0% |
| Feb 2026 | $0.14 | $1.60 | +1,067.9% |
| Nov 2025 | $0.14 | $0.26 | +85.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | $0.21 | — | — | $332.3M | — | — |
| Aug 4, 2026 | $0.07 | $0.18 | +164.1% | $296.6M | $308.0M | +3.8% |
| May 6, 2026 | $0.04 | $0.02 | −50.0% | $280.3M | $268.1M | −4.3% |
| Feb 25, 2026 | $0.14 | $1.60 | +1,067.9% | $292.8M | $284.0M | −3.0% |
| Nov 5, 2025 | $0.14 | $0.26 | +85.7% | $292.6M | $278.6M | −4.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 7, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 27, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 8, 2023 | ||||||
| Feb 27, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 4, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 8, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 5, 2021 | ||||||
| Feb 24, 2021 | ||||||
| Nov 4, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 7, 2020 | ||||||
| Feb 26, 2020 | ||||||
| Oct 30, 2019 | ||||||
| Jul 31, 2019 | ||||||
| May 1, 2019 | ||||||
| Feb 26, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 4, 2018 | ||||||
| Feb 27, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 9, 2017 | ||||||
| Feb 28, 2017 | ||||||
| Nov 7, 2016 | ||||||
| Aug 4, 2016 | ||||||
| May 5, 2016 | ||||||
| Feb 29, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 6, 2015 | ||||||